Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Menopause is a natural biological process that marks the end of a woman's menstrual cycles, typically occurring in the late ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) announced Thursday that elinzanetant, its experimental therapy for hot flashes, reached the ...

As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...

By incorporating these home remedies and avoiding harmful habits, you can start to restore balance to your hormones, feel ...

This article reviews the published literature on the use of venlafaxine, fluoxetine, and paroxetine for the treatment of hot flashes.

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

More than 80% of people get hot flashes at some point before or after menopause. Changing hormones are believed to be the cause of hot flashes and other symptoms of menopause, including anxiety, ...

Effexor XR (venlafaxine) is an antidepressant that has been found to reduce hot flashes in women undergoing treatment for breast cancer. Because it works so well in breast cancer patients, researchers ...